Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
Resource Type
Article
Authors
Sweeney, Christopher ; Bracarda, Sergio ; Sternberg, Cora N ; Chi, Kim N ; Olmos, David ; Sandhu, Shahneen ; Massard, Christophe ; Matsubara, Nobuaki ; Alekseev, Boris ; Parnis, Francis ; Atduev, Vagif ; Buchschacher, Gary L, Jr ; Gafanov, Rustem ; Corrales, Luis ; Borre, Michael ; Stroyakovskiy, Daniil ; Alves, Gustavo Vasconcelos ; Bournakis, Evangelos ; Puente, Javier ; Harle-Yge, Marie-Laurence ; Gallo, Jorge ; Chen, Geng ; Hanover, Justin ; Wongchenko, Matthew J ; Garcia, Josep ; de Bono, Johann S
Source
In The Lancet 10-16 July 2021 398(10295):131-142
Subject
Primary Research Articles
Language
ISSN
0140-6736